Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era
Background: Optimal treatment for patients with stage IIIA NSCLC is controversial. Growing evidence indicates surgery with adjuvant or neoadjuvant chemotherapy (SC) may be superior to non-surgical treatments. Direct comparisons have not been performed between SC and chemoradiation with immunotherapy...
Saved in:
Main Authors: | Amy Alabaster, Jeffrey B. Velotta, Haley I. Tupper, Mark S. Walker, Yanina Natanzon |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294224000649 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
by: Jason C.S. Ho, et al.
Published: (2024-01-01) -
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database
by: Keiko Miyazato, et al.
Published: (2025-02-01) -
Employment status and women's fertility: Do working women have fewer children?
by: Yulmardi Yulmardi, et al.
Published: (2024-12-01) -
Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study
by: Toru Sakurai, et al.
Published: (2024-03-01) -
El papel del agrupamiento escolar en las desigualdades educativas intrarregionales. Una extensión del «Propensity Score Matching» al análisis regional
by: Bruno Blanco-Varela, et al.
Published: (2024-07-01)